Adhesive otitis media

Summary

Adhesive otitis media (MONDO:0001234) is a disease. A subtype of auditory system disorder — broader associated-gene and molecular evidence is on the parent page (see Disease family below).

Clinical features

No curated clinical features (Orphanet) for this disease.

Identifiers

Disease identifiers

Field	Value
Canonical name	adhesive otitis media
Mondo ID	MONDO:0001234
DOID	DOID:11235
ICD-10-CM	H74.1
ICD-11	1692803582
SNOMED CT	7699004
UMLS	C0155478
MedGen	509984
Is cancer (heuristic)	no

Also known as: adhesive middle ear disease · adhesive otitis media · chronic adhesive otitis media

Disease family

This is a subtype of auditory system disorder. Genetic, therapeutic, and trial evidence is largely curated at the broader-term level — see the parent page for the associated-gene cohort and molecular evidence.

Classification path: disease › human disease › disease by body system or component › auditory system disorder › adhesive otitis media

Related subtypes (10): discharging ear, dislocation of ear ossicle, retrocochlear disease, inner ear disorder, external ear disorder, middle ear disorder, auditory system cancer, hearing disorder, inherited auditory system disease, auditory system benign neoplasm

Genetics & variants

GWAS landscape

No GWAS associations recorded — common-variant (GWAS) studies don’t cover this disease (typical for Mendelian / rare diseases). See the curated gene cohort and Mendelian overlap below.

Variant details and genetic-evidence tiers

No tiered GWAS variants or ClinVar records for this disease.

Genes & proteins

No associated-gene cohort resolved for this disease. Atlas builds the molecular and therapeutic sections — associated genes, protein families, druggability, pathways, interactions, and drug associations — by aggregating over a disease’s associated genes (resolved via GWAS / GenCC / ClinVar / CIViC), and none resolved here. This is expected for antibody-mediated, autoimmune, or otherwise non-gene-defined conditions; the curated evidence for this disease is its clinical features, GWAS susceptibility, and clinical trials (above).

Function

No pathway enrichment — requires an associated-gene cohort.

Therapeutics

No druggable-target or therapeutic data for this disease’s cohort.

Clinical trials & evidence

Clinical trials

Clinical trials: 0.